Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Bretz

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Statistics in Medicine|September 3, 2015
Seventh international French Society of Statistics meeting on statistical methods in biopharmacy: emerging topics for statistical methodology in clinical drug developmentFrank Bretz
Statistics in Medicine|May 3, 2019
CorrectionFrank Bretz
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2022
[What Is an Estimand?-The Most Important Clinical Question in Oncology Trials]Toshimitsu Hamasaki, Frank Bretz
Pharmaceutical Statistics|August 4, 2007
Power and sample size when multiple endpoints are consideredStephen Senn, Frank Bretz
Statistics in Medicine|July 12, 2008
Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed testsKlaus Strassburger, Frank Bretz
Pharmaceutical Statistics|September 28, 2010
Sample size and proportion of Japanese patients in multi-regional trialsKimitoshi Ikeda, Frank Bretz
Statistics in Medicine|July 22, 2014
A note on testing families of hypotheses using graphical proceduresWilli Maurer, Frank Bretz
BMC Medical Research Methodology|September 21, 2005
Adaptive designs based on the truncated product methodMarkus Neuhäuser, Frank Bretz
Biometrical Journal. Biometrische Zeitschrift|June 12, 2021
Discussion on 'Correct and logical causal inference for binary and time-to-event outcomes in randomized controlled trials'Dong Xi, Frank Bretz
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2022
[Multiple Endpoints in Oncology Clinical Trials]Toshimitsu Hamasaki, Frank Bretz
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Statistics in Medicine|September 3, 2015
Seventh international French Society of Statistics meeting on statistical methods in biopharmacy: emerging topics for statistical methodology in clinical drug developmentFrank Bretz
Statistics in Medicine|May 3, 2019
CorrectionFrank Bretz
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2022
[What Is an Estimand?-The Most Important Clinical Question in Oncology Trials]Toshimitsu Hamasaki, Frank Bretz
Pharmaceutical Statistics|August 4, 2007
Power and sample size when multiple endpoints are consideredStephen Senn, Frank Bretz
Statistics in Medicine|July 12, 2008
Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed testsKlaus Strassburger, Frank Bretz
Pharmaceutical Statistics|September 28, 2010
Sample size and proportion of Japanese patients in multi-regional trialsKimitoshi Ikeda, Frank Bretz
Statistics in Medicine|July 22, 2014
A note on testing families of hypotheses using graphical proceduresWilli Maurer, Frank Bretz
BMC Medical Research Methodology|September 21, 2005
Adaptive designs based on the truncated product methodMarkus Neuhäuser, Frank Bretz
Biometrical Journal. Biometrische Zeitschrift|June 12, 2021
Discussion on 'Correct and logical causal inference for binary and time-to-event outcomes in randomized controlled trials'Dong Xi, Frank Bretz
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2022
[Multiple Endpoints in Oncology Clinical Trials]Toshimitsu Hamasaki, Frank Bretz
Pageof 12